Outcomes after chemotherapy with WHO category II regimen in a population with high prevalence of drug resistant tuberculosis. by Francine Matthys, Leen Rigouts, Vinciane Sizaire, Natalia Vezhnina, Maryvonne Lecoq, Vera Golubeva, Françoise Portaels, Patrick Van der Stuyft, Michael Kimerling

Get full text